Basile Chrétien
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- CAR-T cell therapy research
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
- Toxicology 16
- Pharmacovigilance and Adverse Drug Reactions 14
- Surgery 7
- Heparin-Induced Thrombocytopenia and Thrombosis 3
- Co-authors
- Joachim Alexandre (29 shared papers)Charles Dolladille (30 shared papers)Sophie Fédrizzi (21 shared papers)Marion Sassier (15 shared papers)Véronique Lelong‐Boulouard (16 shared papers)Angélique Da Silva (7 shared papers)Damien Legallois (3 shared papers)Stéphane Éderhy (1 shared paper)
- Journals
- BMJ Open (2 papers)JAMA Oncology (2 papers)Psychological Medicine (2 papers)British Journal of Clinical Pharmacology (2 papers)Clinical Pharmacology & Therapeutics (2 papers)
- Partner nations
- FranceJapanUnited States
In The Last Decade
Basile Chrétien
42 papers receiving 932 citations
Basile Chrétien's Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 487
- Toxicology 41
- Genetics 53
- Pulmonary and Respiratory Medicine 147
- Neurology 64
Countries citing papers authored by Basile Chrétien
This map shows the geographic impact of Basile Chrétien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Basile Chrétien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Basile Chrétien more than expected).
Fields of papers citing papers by Basile Chrétien
This network shows the impact of papers produced by Basile Chrétien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Basile Chrétien. The network helps show where Basile Chrétien may publish in the future.
Co-authors
The 25 scholars most cited alongside Basile Chrétien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer Hit paper breakdown → | 2020 | 394 |
| 2 | 2020 | 161 | |
| 3 | 1991 | 128 | |
| 4 | 1975 | 49 | |
| 5 | 2020 | 31 | |
| 6 | 2021 | 27 | |
| 7 | 2017 | 19 | |
| 8 | 2019 | 19 | |
| 9 | 2020 | 18 | |
| 10 | 2018 | 13 | |
| 11 | 2021 | 13 | |
| 12 | 2023 | 9 | |
| 13 | 2022 | 7 | |
| 14 | 2023 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2020 | 5 | |
| 17 | 2024 | 5 | |
| 18 | 2022 | 4 | |
| 19 | 2018 | 4 | |
| 20 | 2024 | 4 |
About Basile Chrétien
Basile Chrétien is a scholar working on Toxicology, Surgery, Pulmonary and Respiratory Medicine, Oncology and Psychiatry and Mental health, having authored 55 papers that have together received 961 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (14 papers), Schizophrenia research and treatment (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Heparin-Induced Thrombocytopenia and Thrombosis (3 papers), Advanced Breast Cancer Therapies (3 papers), Pharmaceutical industry and healthcare (2 papers) and Vasculitis and related conditions (2 papers). The work is most often cited by research in Oncology (487 citations), Toxicology (41 citations), Genetics (53 citations), Pulmonary and Respiratory Medicine (147 citations) and Neurology (64 citations). Basile Chrétien has collaborated with scholars based in France, Japan and United States. Frequent co-authors include Joachim Alexandre, Charles Dolladille, Sophie Fédrizzi, Marion Sassier, Véronique Lelong‐Boulouard, Angélique Da Silva, Damien Legallois, Stéphane Éderhy, Anne‐Flore Plane and Jennifer Cautela. Their work appears in journals such as BMJ Open, JAMA Oncology, Psychological Medicine, British Journal of Clinical Pharmacology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.